Aberdeen Asset Management’s Prestige Consumer Healthcare PBH Stock Holding History

Aberdeen Asset Management’s Portfolio PBH Stock Details PBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$50.2M	Buy	950,505 +131,978	+16%	+$7.07M	0.17%	114
2017 Q1	$45.5M	Sell	818,527 -195,895	-19%	-$10.8M	0.16%	118
2016 Q4	$52.9M	Buy	1,014,422 +377,629	+59%	+$18.2M	0.2%	87
2016 Q3	$30.7M	Buy	636,793 +236,935	+59%	+$12M	0.11%	151
2016 Q2	$22.2M	Buy	399,858 +195,211	+95%	+$10.8M	0.08%	192
2016 Q1	$10.9M	Buy	204,647 +44,114	+27%	+$2.17M	0.04%	281
2015 Q4	$7.61M	Buy	160,533 +40,700	+34%	+$2.02M	0.03%	340
2015 Q3	$5.41M	Buy	+119,833	New	+$5.66M	0.02%	356

Other funds holding PBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MRCP

Manor Road Capital Partners New York $63.8M AUM 19.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Aberdeen Asset Management's PBH Position: Q2 2017 in Review

Aberdeen Asset Management increased its Prestige Consumer Healthcare (PBH) stake by 16% in Q2 2017, buying an estimated $7.07M and bringing the position to 950,505 shares worth $50.2M. The position accounts for 0.17% of the portfolio, ranked #114.

Aberdeen Asset Management first reported a position in PBH in Q3 2015 and has held it in 8 quarters since. The position peaked at $52.9M in Q4 2016. 232 funds tracked by Wall St. Rank hold PBH as of Q2 2017.

Aberdeen Asset Management held 950,505 shares of Prestige Consumer Healthcare worth $50.2M as of Q2 2017.
Aberdeen Asset Management bought 131,978 Prestige Consumer Healthcare shares in Q2 2017, an estimated $7.07M.
Prestige Consumer Healthcare made up 0.17% of Aberdeen Asset Management's portfolio in Q2 2017, its #114 holding.
Aberdeen Asset Management first reported a position in Prestige Consumer Healthcare in Q3 2015 and has held it in 8 quarters since.
Aberdeen Asset Management's Prestige Consumer Healthcare position peaked at $52.9M in Q4 2016.
232 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2017.

Based on Aberdeen Asset Management's 13F filing for Q2 2017, filed 10 Aug 2017.